Soft Tissue Sarcoma

NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma

Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma

Phase II Study of TAEST16001 in Soft Tissue Sarcoma

Toripalimab Combined With CAV/IE Regimen

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

APX005M and Doxorubicin in Advanced Sarcoma

5-Day Preoperative Radiation for Soft Tissue Sarcoma

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

Preoperative Immunonutrition in Patients With Bone and Soft Tissue Sarcomas

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma